1. A novel gene–protein assay for evaluating HER2 status in gastric cancer: simultaneous analyses of HER2 protein overexpression and gene amplification reveal intratumoral heterogeneity
   Yasunori Nishida et al, 2015, Gastric Cancer CrossRef
2. B Cell Epitope-Based Vaccination Therapy
   Yoshie Kametani et al, 2015, Antibodies CrossRef
3. HER2 expression in locally advanced gastric cancer with extensive lymph node (bulky N2 or paraaortic) metastasis (JCOG1005-A trial)
   Tomohiro Matsumoto et al, 2015, Gastric Cancer CrossRef
4. Association of HER2 status with prognosis in gastric cancer patients undergoing R0 resection: A large-scale multicenter study in China
   Guo-Shuang Shen et al, 2016, WJG CrossRef
5. HER2 testing in gastric cancer: An update
   Lucas Faria Abrahao-Machado et al, 2016, WJG CrossRef
6. Serum HER2 as a predictive biomarker for tissue HER2 status and prognosis in patients with gastric cancer
   Hong-Zhi Shi et al, 2017, WJG CrossRef
7. Current and emerging therapies in unresectable and recurrent gastric cancer
   Erin Jou et al, 2016, WJG CrossRef
8. HER2 heterogeneity in gastric/gastroesophageal cancers: From benchside to practice
   Federica Grillo et al, 2016, WJG CrossRef
9. Disparities in Gastric Cancer Chemotherapy Between the East and West
   Atsushi Ohtsu et al, 2006, JCO CrossRef
10. null
    Yu Sawada et al, 2011, JJCS CrossRef
11. HER2 expression and its clinicopathological features in resectable gastric cancer
    Yoshiki Kataoka et al, 2013, Gastric Cancer CrossRef
12. HER2-positive gastric cancer.
    Narikazu Boku, 2014, Gastric Cancer CrossRef
13. Human epidermal growth factor receptor-2 expression in primary and metastatic gastric cancer
    Yiting Geng et al, 2014, Int J Clin Oncol CrossRef
14. HER2 Status in Rarer Histologic Types of Gastric Adenocarcinomas
    Valeria Barresi et al, 2013, Archives of Pathology & Laboratory Medicine CrossRef
15. A Complete Response Case of Gastric Cancer to Intravenous and Intraperitoneal Paclitaxel Combined with S-1 and Trastuzumab
    Nobumitsu Shiina et al, 2013, JJCS CrossRef
16. Texture Analysis of Breast DCE-MRI Based on Intratumoral Subregions for Predicting HER2 2+ Status
    Hecheng Lu et al, 2020, Front. Oncol. CrossRef
17. GRAM domain-containing protein 1B (GRAMD1B), a novel component of the JAK/STAT signaling pathway, functions in gastric carcinogenesis
    Puja Khanna et al, 2017, Oncotarget CrossRef
18. CURRENT POINT OF VIEW ON PROGNOSTIC AND PREDICTIVE ROLES AND PRACTICAL APPLICATION OF HER2 RECEPTOR’S DETECTION. LITERATURE REVIEW
    D. L. Rotin et al, 2020, Rossijskij bioterapevtičeskij žurnal CrossRef
19. Development of HER2-targeted Therapies for Gastrointestinal Cancer
    Kentaro Sawada et al, 2020 CrossRef
20. Intergenerational comparison of 5-HT3RA in the prevention of chemotherapy-induced nausea and vomiting in gastric cancer patients receiving cisplatin-based chemotherapy: an observational study using a Japanese administrative claims database
    Yuji Kunitomi et al, 2021, Support Care Cancer CrossRef
21. Study of prognostic indicators and Her2neu expression in gastric adenocarcinomas – A tertiary care centre study
    Ravi M Swami et al, 2021, IJPO CrossRef
22. null
    Sonia Thapa et al, 2021 CrossRef
23. Molecular Dissection of 17q12 Amplicon in Upper Gastrointestinal Adenocarcinomas
    Nazif Maqani et al, 2006 CrossRef
24. Impact of insulin-like growth factor type 1 receptor, epidermal growth factor receptor, and HER2 expressions on outcomes of patients with gastric cancer.
    Junichi Matsubara et al, 2008, Clin. Cancer Res. CrossRef
25. HER2 Regulates Cancer Stem Cell Activities via the Wnt Signaling Pathway in Gastric Cancer Cells.
    Da Hyun Jung et al, 2019, Oncology CrossRef
26. Development of the B cell cancer vaccine HER-vaxx for the treatment of her-2 expressing cancers
    Nicholas J. Ede et al, 2022, Front. Oncol. CrossRef